Professor Chloe Orkin

Mutta siellä on ryhmä ihmisiä, jotka eivät ole voineet hyödyntää terveyden edistämisestä, jotta heidän on voinut ottaa yhden pillin päivä. Ja nämä ovat yleensä ihmisiä, jotka olivat diagnoostuneet hyvin alussa HIV-epidemian aikana, kun opimme, miten käsitellään HIV. Ja meitämme väärin pillit ja se edusti edistämisestä erilaisista HIV-verkostoista.

Joten tämän jälkeen nämä ihmiset, kuten kaikki muu, pitää ottaa paljon polttoaineita ja usein kaksi päivää päivänä edelleen HIV-vaihtoehtoille. Joten todennäköisesti aikaa on edelleen ollut nämä ihmiset, mutta myös jotkut ihmiset, jotka olivat syntyneet HIV-vaihtoehtoon.

have been living with HIV for a long time and have resistance, so they also can't take the newer medications. And one of the big concerns about them being on these complex regimens is that they have drug interactions with other commonly prescribed medications. So this is a very new combination with a new class of drug, which is giving them the opportunity to take a single tablet. Professor Chloe Orkin from London's Queen Mary University.

This is the Global News Podcast from the BBC World Service.

For most people living with HIV, it's very simple.

They take a single tablet every day or two monthly injectables.

But there's a group of people who have not been able to benefit from medical advances allowing them to take a single pill a day.

And these are typically people who were diagnosed very early on in the HIV epidemic when we were learning how to treat HIV.

And we gave inadequate pills and that led to the development of resistance to different types of HIV drugs.

So the result of this is that these individuals, unlike everybody else, have to take lots of pills and in many cases twice a day.

still for their HIV.

So effectively, time has stood still for these individuals.

But also some people who were born with HIV have been living with HIV for a long time and have resistance.

So they also can't take the newer medications.

And one of the big concerns about them being on these complex regimens is

is that they have drug interactions with other commonly prescribed medications.

So this is a very new combination with a new class of drug, which is giving them the opportunity to take a single tablet.

To cultural icons.

Two-time Oscar-winning actor Sir Anthony Hopkins.

The interview from the BBC World Service.